Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Micrornas Modulation by Curcumin, Catalpol, and Other Natural Products in Alzheimer’S Disease: A Review Publisher Pubmed



Chahardehi AM1 ; Arefnezhad R1, 2 ; Pourbafrani A3 ; Tajik L4 ; Asadi SA5 ; Salehi H6 ; Yazdanian S7 ; Nakhaee A8 ; Esfahani MS9 ; Behzad P10 ; Haghani H1, 11 ; Niknam Z12 ; Sefati N13 ; Rezaeitazangi F14 Show All Authors
Authors
  1. Chahardehi AM1
  2. Arefnezhad R1, 2
  3. Pourbafrani A3
  4. Tajik L4
  5. Asadi SA5
  6. Salehi H6
  7. Yazdanian S7
  8. Nakhaee A8
  9. Esfahani MS9
  10. Behzad P10
  11. Haghani H1, 11
  12. Niknam Z12
  13. Sefati N13
  14. Rezaeitazangi F14
  15. Tavakoli MR15

Source: Molecular Biology Reports Published:2025


Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with limited pharmacological treatment options, necessitating the exploration of alternative therapeutic strategies. Emerging evidence suggests that microRNAs (miRNAs), such as miR-132, miR-34a, and miR-124, play crucial roles in AD pathogenesis, influencing amyloid-beta (Aβ) aggregation, tau phosphorylation, neuroinflammation, and oxidative stress. Natural products have been identified as potential modulators of miRNA expression, offering neuroprotective benefits through multi-target mechanisms. This review systematically examines the impact of curcumin, catalpol, Allium jesdianum, Tanshinone IIA (Tan IIA), and Tiaoxin Recipe (TXR) on miRNA regulation in AD, summarizing their molecular targets and therapeutic potential. Furthermore, we discuss challenges related to bioavailability and clinical translation, highlighting the need for advanced delivery systems and personalized medicine approaches. By integrating recent findings, this review provides a comprehensive perspective on the role of miRNA modulation in AD therapy and underscores the potential of natural products as novel therapeutic agents. © The Author(s), under exclusive licence to Springer Nature B.V. 2025.
Related Docs
View other Related Docs
1. Microrna in Alzheimer's Disease Revisited: Implications for Major Neuropathological Mechanisms, Reviews in the Neurosciences (2018)
2. Role of Natural Products for the Treatment of Alzheimer's Disease, European Journal of Pharmacology (2021)
3. Circular Rnas in Alzheimer’S Disease: A New Perspective of Diagnostic and Therapeutic Targets, CNS and Neurological Disorders - Drug Targets (2023)
Experts (# of related papers)
View all Related Experts
Ahmad Reza Dehpour (2)
Nima Rezaei (1)
Other Related Docs
4. Secretases-Related Mirnas in Alzheimer’S Disease: New Approach for Biomarker Discovery, Neurological Sciences (2017)
5. Exosomes and Micrornas: New Potential Therapeutic Candidates in Alzheimer Disease Therapy, Journal of Cellular Physiology (2019)
6. Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and Pi3/Akt/ Gsk3 or Pi3/Akt/Creb/Bdnf Signaling Pathways, International Journal of Molecular and Cellular Medicine (2020)
7. A Novel Approach to Type 3 Diabetes Mechanism: The Interplay Between Noncoding Rnas and Insulin Signaling Pathway in Alzheimer's Disease, Journal of Cellular Physiology (2022)
8. Non-Coding Rnas and Neurodegenerative Diseases: Information of Their Roles in Apoptosis, Molecular Neurobiology (2023)
9. Prospects of Saffron and Its Derivatives in Alzheimer's Disease, Archives of Iranian Medicine (2021)
10. Exploring the Molecular Mechanisms of Curcumin in Modulating Memory Impairment in Neurodegenerative Disorders, Molecular Biology Reports (2025)
11. A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration With Implications for Alzheimer’S Disease, Mini-Reviews in Medicinal Chemistry (2020)
12. Molecular Mechanisms Underlying Curcumin-Mediated Microrna Regulation in Carcinogenesis; Focused on Gastrointestinal Cancers, Biomedicine and Pharmacotherapy (2021)
13. Effects of Micrornas and Long Non-Coding Rnas on Beneficial Action of Exercise on Cognition in Degenerative Diseases: A Review, Molecular Neurobiology (2025)
14. Beta-Amyloid-Dependent Mirnas As Circulating Biomarkers in Alzheimer’S Disease: A Preliminary Report, Journal of Molecular Neuroscience (2020)
15. Multifunctional Iminochromene-2H-Carboxamide Derivatives Containing Different Aminomethylene Triazole With Bace1 Inhibitory, Neuroprotective and Metal Chelating Properties Targeting Alzheimer's Disease, European Journal of Medicinal Chemistry (2017)
16. Naturally Occurring Chemicals Against Alzheimer’S Disease, Naturally Occurring Chemicals against Alzheimer’s Disease (2020)
17. Efficient Roles of Mir-146A in Cellular and Molecular Mechanisms of Neuroinflammatory Disorders: An Effectual Review in Neuroimmunology, Immunology Letters (2021)
18. Curcumin and Targeting of Molecular and Metabolic Pathways in Multiple Sclerosis, Cell Biochemistry and Function (2023)
19. Microrna As a Potential Diagnostic and Prognostic Biomarker in Brain Gliomas: A Systematic Review and Meta-Analysis, Frontiers in Neurology (2024)
20. Nanoformulated Herbal Bioactives for the Treatment of Neurodegenerative Disorders, Herbal Bioactive-Based Drug Delivery Systems: Challenges and Opportunities (2022)